Related Experiment Videos
High-frequency oscillatory ventilation in adults: the Toronto experience
Sangeeta Mehta1, John Granton, Rod J MacDonald
1Mount Sinai Hospital, 600 University Ave, No. 1818, Toronto, ON, Canada, M5G 1X5. geeta.mehta@utoronto.ca
Chest
|August 11, 2004
Summary
High-frequency oscillatory ventilation (HFOV) improved oxygenation in severe acute respiratory distress syndrome (ARDS) patients. Early HFOV initiation may be beneficial, though mortality remains high.
Area of Science:
- Critical Care Medicine
- Respiratory Physiology
- Mechanical Ventilation
Background:
- Severe acute respiratory distress syndrome (ARDS) presents significant challenges in oxygenation and ventilation.
- Conventional ventilation (CV) may be insufficient for patients with refractory hypoxemia.
Purpose of the Study:
- To evaluate the clinical outcomes of high-frequency oscillatory ventilation (HFOV) in adult patients with severe ARDS.
- To describe patient characteristics, HFOV management strategies, and associated outcomes in a real-world ICU setting.
Main Methods:
- Retrospective chart review of 156 adult patients with severe ARDS treated with HFOV across three ICUs.
- Data collection included demographics, respiratory failure etiology, ventilator settings, gas exchange, hemodynamics, and mortality.
Main Results:
- HFOV significantly improved PaO2/FiO2 ratios and oxygenation index (OI), with benefits sustained up to 72 hours.
- Hemodynamic changes included increased CVP and PAOP, with decreased cardiac output.
- Thirty-day mortality was 61.7%; predictors of mortality included older age, higher APACHE II score, and delayed HFOV initiation.
Conclusions:
- HFOV demonstrates beneficial effects on oxygenation and OI in severe ARDS, suggesting its utility as a rescue therapy.
- Early implementation of HFOV may enhance patient outcomes in severe oxygenation failure.